A Phase 2a, Open Label, Dose Escalation Study for Safety, Tolerability, and Efficacy of Hepatocyte Transplantation Into Periduodenal Lymph Nodes Among Subjects With End-Stage Liver Disease
This Phase 2a clinical trial is a dose escalation study of the safety, tolerability, and efficacy of hepatocyte transplantation into lymph nodes via endoscopic ultrasound among subjects with end-stage liver disease.
100 项与 LYG-LIV0001 相关的临床结果
100 项与 LYG-LIV0001 相关的转化医学
100 项与 LYG-LIV0001 相关的专利(医药)
100 项与 LYG-LIV0001 相关的药物交易